News
TEVA
17.16
+3.56%
0.59
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q4 2024 Update
Seeking Alpha · 1d ago
Teva and Alvotech gets FDA review acceptance for its proposed biosimilar to Eylea
Seeking Alpha · 1d ago
Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)
Barchart · 1d ago
BUZZ-U.S. STOCKS ON THE MOVE-Wynn Resorts, Southwest Airlines, Extreme Networks
Reuters · 1d ago
BUZZ-Teva rises as FDA accepts to review biosimilar to eye disease drug Eylea
Reuters · 1d ago
FDA Accepts BLA For AVT06, Proposed Biosimilar To Eylea For Retinal Diseases
NASDAQ · 1d ago
Alvotech and Teva’s BLA filing for AVT06 accepted by FDA
TipRanks · 1d ago
FDA To Review BLA For Alvotech's Proposed Biosimilar To Eylea - Quick Facts
NASDAQ · 1d ago
ALVOTECH SA - FDA ACCEPTS FOR REVIEW BLA FOR ALVOTECH'S BIOSIMILAR TO EYLEA
Reuters · 1d ago
ALVOTECH AND TEVA ANNOUNCE FILING ACCEPTANCE OF U.S. BIOLOGICS LICENSE APPLICATION FOR AVT06, A PROPOSED BIOSIMILAR TO EYLEA® (AFLIBERCEPT)
Reuters · 1d ago
ALVOTECH SA - REGULATORY APPROVAL FOR AVT06 EXPECTED BY Q4 2025
Reuters · 1d ago
Billionaire Investor Stanley Druckenmiller Dumps Broadcom, Bets Big On Tesla, Amazon And Other Big Tech Stocks In Q4
Benzinga · 1d ago
Validea Detailed Fundamental Analysis - TEVA
NASDAQ · 2d ago
Weekly Report: what happened at TEVA last week (0210-0214)?
Weekly Report · 2d ago
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Benzinga · 3d ago
This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy?
The Motley Fool · 3d ago
Top Executive Unloads Massive Teva Stock Stake, Raking in Millions!
TipRanks · 4d ago
Druckenmiller's Duquesne adds airlines, exits Microsoft, Broadcom, others
Seeking Alpha · 4d ago
iShares Currency Hedged MSCI EAFE ETF Experiences Big Inflow
NASDAQ · 5d ago
Janus Henderson Global Life Sciences Diversified ADR Managed Account Q4 2024 Commentary
Seeking Alpha · 5d ago
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.